Comparison of chelating agents DMPS, DMSA and EDTA for the diagnosis and treatment of chronic metal exposure.

@article{BlaurockBusch2014ComparisonOC,
  title={Comparison of chelating agents DMPS, DMSA and EDTA for the diagnosis and treatment of chronic metal exposure.},
  author={Eleonor Blaurock-Busch and Yvette M. Busch},
  journal={British journal of medicine and medical research},
  year={2014},
  volume={4},
  pages={1821-1835}
}
Aims: Several chelating agents are presently used among environmental physicians to diagnose and treat a chronic metal overexposure. We evaluated and compared the binding capacity of the most common chelating agents DMPS (2, 3-dimercapto-1propanesulfonic acid), DMSA (dimercaptosuccinic acid), also called Succimer) and EDTA (ethylene diamine tetraacetic acid) for the potentially toxic metals Antimony (Sb), Arsenic (As), Cadmium (Cd), Lead (Pb) and Mercury (Hg). Secondly, we evaluated how the… 

Figures and Tables from this paper

Comparative effects of meso-2,3- dimercaptosuccinic acid, monensin, and salinomycin on cadmium-induced brain dysfunction in cadmium-intoxicated mice

Salinomycin is demonstrated to be a better potential chelating agent for treatment of Cd-induced brain injury compared to DMSA and monensin.

Synergistic protective effect of Betavulgaris with meso-2,3-dimercaptosuccinic acid against lead-induced neurotoxicity in male rats

Beta vulgaris juice has a powerful efficacy in the protection from brain toxicity via diminishing Pb in the brain and blood circulation, resulting in the prevention of the oxidative and inflammatory stress.

The synergistic hepatoprotective potential of Beta vulgaris juice and 2,3- dimercaptosuccinic acid in lead-intoxicated rats via improving the hepatic oxidative and inflammatory stress

BVJ has a potent efficiency in the protection from Pb-induced hepatotoxicity through the reduction of its accumulation in blood and liver and the prevention of the oxidative stress and inflammation induced by Pb.

Ameliorative effect of the anticancer agent salinomycin on cadmium-induced hepatotoxicity and renal dysfunction in mice

The results confirm that the anticancer agent salinomycin is a promising antidote to Cd poisoning.

The Biochemical Outcome of two Treatment Protocols in Patients With Opium-associated Lead Poisoning: A Cross-sectional Study in North of Iran

Although DMSP decreases BLL significantly and reverses liver enzymes, further investigations on Hb and RBC are needed, according to the results, penicillamine improves low to moderate lead toxicity.

Effects of Zinc Chelators on Aflatoxin Production in Aspergillus parasiticus

The data suggest that TPEN binds to cytoplasmic zinc therefore limiting fungal access to zinc, and provides the basis for biological differences that exist in the efficacy of different zinc chelators in various food and feed crops frequently contaminated by aflatoxin.

Whole-cell bioreporters and risk assessment of environmental pollution: A proof-of-concept study using lead.

Ameliorative effects of deferiprone and tetraethylammonium salt of salinomycinic acid on lead-induced toxicity in mouse testes

The results demonstrated that Pb exposure significantly increased blood and testicular Pb concentrations, decreased testicular calcium (Ca) content, and significantly elevated testicular levels of magnesium, zinc, and selenium but did not significantly affect the endogenous contents of phosphorous (P) and iron (Fe) compared with untreated controls.

The management of embedded metal fragment patients and the role of chelation Therapy: A workshop of the Department of Veterans Affairs-Walter Reed National Medical Center.

The evidence presented suggests that, at least in the case of lead fragments, short-term chelation therapy may be beneficial for embedded fragment patients experiencing acute symptoms associated with metal toxicity; however, in the absence of clinical symptoms or significantly elevated blood lead concentrations, chelation Therapy may offer little to no benefit.

References

SHOWING 1-10 OF 39 REFERENCES

DMSA and DMPS--water soluble antidotes for heavy metal poisoning.

  • H. Aposhian
  • Chemistry
    Annual review of pharmacology and toxicology
  • 1983
This article reviews the pharmacological properties and the uses of two important antidotes for heavy metal poisoning, DMSA and DMPS, water soluble chemical analogs of dimercaprol, which have less toxicity, greater water solubility, and lim­ ited lipid solubilities, and are effective when given orally.

Role of chelating agents for prevention, intervention, and treatment of exposures to toxic metals.

ence was prompted by emerging evidence that low-level exposures to metals may result in toxic effects not previously recog? nized. For example, the recent interest in use of chelation as an

The benefits of pre- and post-challenge urine heavy metal testing: Part 1.

  • W. Crinnion
  • Medicine
    Alternative medicine review : a journal of clinical therapeutic
  • 2009
By utilizing both pre- and post-flush testing, the clinician gains information that cannot be acquired by other means, including identification of current exposures to lead and mercury - critical for proper treatment.

Determination and metabolism of dithiol chelating agents. XVI: Pharmacokinetics of 2,3-dimercapto-1-propanesulfonate after intravenous administration to human volunteers.

The pharmacokinetics of 2,3-dimercaptopropane-1-sulfonate (DMPS), an effective chelating agent for mercury, were determined in five healthy adults after i.v. administration of 3.0 mg/kg of DMPS. DMPS

Biological mercury measurements before and after administration of a chelator (DMPS) and subjective symptoms allegedly due to amalgam.

The chelator was considered neither to invalidate nor to improve these findings and was concluded not to be helpful in diagnosing "symptoms" and caused side effects in 42% of the subjects and the placebo in 27%.

A cluster of pediatric metallic mercury exposure cases treated with meso-2,3-dimercaptosuccinic acid (DMSA)

Oral chelation with DMSA appears to be an effective and safe chelating agent for treatment of pediatric overexposure to metallic mercury and no adverse side effects were observed.

ORAL CHELATION THERAPY FOR PATIENTS WITH LEAD POISONING

There is now evidence-based guidance available for managing children with increased lead exposure and the focus in childhood lead-poisoning policy should shift from case identification and management to primary prevention, with a goal of safe housing for all children.

The benefit of pre- and post-challenge urine heavy metal testing: part 2.

  • W. Crinnion
  • Medicine
    Alternative medicine review : a journal of clinical therapeutic
  • 2009
It is recommended that clinicians do heavy metal testing both before and after a challenge with an effective and proven heavy metal mobilizing agent.